A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer

Roche

Status: Completed

Conditions: Breast Cancer

Treatments: Other: eBC treated participants

Study type: Observational

Funder types: Industry

Identifiers

NCT02761616

ML30038

Details and patient eligibility

About

This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.

Enrollment: 76 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participants with histologically confirmed breast cancer treated for early breast cancer (eBC) with first metastatic relapse disease in the period from January 1, 2014 and December 31, 2015

Exclusion criteria

Not Applicable

Trial design

76 participants in 1 patient group

eBC treated participants

Description:

Participants with metastatic disease after previously being treated for eBC were observed for 24 months.

Treatment:

Other: eBC treated participants